Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

CollPlant Biotechnologies (CLGN) Other Operating Expenses (2018 - 2023)

Historic Other Operating Expenses for CollPlant Biotechnologies (CLGN) over the last 4 years, with Q1 2023 value amounting to -$3.4 million.

  • CollPlant Biotechnologies' Other Operating Expenses rose 754.51% to -$3.4 million in Q1 2023 from the same period last year, while for Dec 2023 it was -$3.4 million, marking a year-over-year increase of 754.51%. This contributed to the annual value of -$8.8 million for FY2020, which is 8382.85% down from last year.
  • According to the latest figures from Q1 2023, CollPlant Biotechnologies' Other Operating Expenses is -$3.4 million, which was up 754.51% from -$3.7 million recorded in Q1 2022.
  • CollPlant Biotechnologies' Other Operating Expenses' 5-year high stood at -$398000.0 during Q3 2019, with a 5-year trough of -$4.3 million in Q4 2019.
  • For the 3-year period, CollPlant Biotechnologies' Other Operating Expenses averaged around -$2.3 million, with its median value being -$2.6 million (2019).
  • Examining YoY changes over the last 5 years, CollPlant Biotechnologies' Other Operating Expenses showed a top increase of 4699.69% in 2019 and a maximum decrease of 27847.53% in 2019.
  • CollPlant Biotechnologies' Other Operating Expenses (Quarter) stood at -$4.3 million in 2019, then grew by 14.55% to -$3.7 million in 2022, then increased by 7.55% to -$3.4 million in 2023.
  • Its last three reported values are -$3.4 million in Q1 2023, -$3.7 million for Q1 2022, and -$4.3 million during Q4 2019.